FindTrial
Sign In

Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis

Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis - Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000043459
Enrollment
1000
Registered
2021-02-27
Start date
2021-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all observational studies or trials involving adult patients with COVID-19 that had any data of anticoagulation use for comparison poor vs good outcome

Exclusion criteria

Exclusion criteria: missing required data, no data on anticoagulant use, no outcome of interest, other than english language

Design outcomes

Primary

MeasureTime frame
Bleeding rate in each anticoagulation dosing—

Secondary

MeasureTime frame
Mortality rate in each anticoagulation dosing—

Countries

Asia(except Japan)

Contacts

Public ContactEka Mulia

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia Department of Cardiology and Vascular Medicine

eka.prasetya.budi-2017@fk.unair.ac.id628562765365

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026